Surgical Therapy for Heart Failure

Journal of the American College of Surgeons

Volumn 203, Issue 2, 2006, Pages 226-239

  Selzman, Craig H ^a   Bhati, Rajendra S ^a   Sheridan, Brett C ^a   Stansfield, William E ^a   Mill, Michael R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CARVEDILOL; CYCLOSPORIN; CYTOKINE RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; LOOP DIURETIC AGENT; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THIAZIDE DIURETIC AGENT; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ACUTE HEART INFARCTION; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG HYPERSENSITIVITY; EPIDEMIC; EXTRACORPOREAL OXYGENATION; HEALTH CARE COST; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW;

CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; UNITED STATES;

EID: 33746090887     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2006.04.022     Document Type: Review

References (94)

1. Comarow A., and Healy B. The future is now. US News World Rep 135 19 (2003) 41-70
2. Lloyd-Jones D.M., Larson M.G., Leip E.P., et al. Lifetime risk for developing congestive heart failure. the Framingham Heart Study. Circulation 106 (2002) 3068-3072
3. Heart Disease and Stroke Statistics-Updates 2005 (2005), American Heart Association, Dallas, TX
4. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
5. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 38 (2001) 2101-2113
6. Kostis J.B., Davis B.R., Cutler J., et al., SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 278 (1997) 212-216
7. Garg R., Yusuf S., and Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273 (1995) 1450-1456
8. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 9169 (1999) 2001-2007
9. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
10. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
11. Elkayam U., and Bitar F. Effects of nitrates and hydralazine in heart failure. clinical evidence before the African American heart failure trial. Am J Cardiol 96 7B (2005) 37i-43i
12. Fruitman D.S., MacDougall C.E., and Ross D.B. Cardiac surgery in octogenarians: can elderly patients benefit? Quality of life after cardiac surgery. Ann Thorac Surg 68 (1999) 2129-2135
13. Scott B.H., Seifert F.C., Grimson R., and Glass P.S. Octogenarians undergoing coronary artery bypass graft surgery. resource utilization, postoperative mortality, and morbidity. J Cardiothorac Vasc Anesth 19 (2005) 583-588
14. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation. twenty-second official adult heart transplant report. J Heart Lung Transplant 24 (2005) 945-955
15. Cimato T.R., and Jessup M. Recipient selection in cardiac transplantation. contraindications and risk factors for mortality. J Heart Lung Transplant 21 (2002) 1161-1173
16. Lower R.R., Dong Jr. E., and Shumway N.E. Long-term survival of cardiac homografts. Surgery 58 (1965) 110-119
17. Eisen H.J., Kobashigawa J., Keogh A., et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 517-525
18. Eisen H., and Ross H. Optimizing the immunosuppressive regimen in heart transplantation. J Heart Lung Transplant 23 Suppl (2004) S207-S213
19. Transplant Statistics. 2004 OPTN/SRTR Annual Report: HHS/HRSA/HSB/DOT (2004), UNOS; URREA
20. Centers for Disease Control and Prevention (CDC). Changes in mortality from heart failure. MMWR Morb Mortal Wkly Rep 47 (1998) 637-663
21. Stevenson L.W., Kormos R.L., Bourge R.C., et al. Mechanical cardiac support 2000. current applications and future trial design. J Am Coll Cardiol 37 (2001) 340-370 June 15-16, 2000 Bethesda, Maryland
22. Expert panel review of the NHLBI total artificial heart (TAH) program, June 1998-November 1999. Available at: http://www.nhlbi.nih.gov/resources/docs/tahrpt.pdf.
23. The VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation 86 (1992) 121-130
24. Caracciolo E.A., Davis K.B., Sopko G., et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation 91 (1995) 2335-2344
25. Elefteriades J.A., Morales D.L., Gradel C., et al. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or = 30%. Am J Cardiol 79 (1997) 1573-1578
26. Kron I., Flanagan T., Blackbourne L., Schroeder R., and Nolan S. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 210 (1989) 352-354
27. Robinson T.N., Morrell T.D., Pomerantz B.J., et al. Therapeutically accessible clinical cardiac states. J Am Coll Surg 191 (2000) 452-463
28. Senior R., Lahiri A., and Kaul S. Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. Am J Cardiol 88 (2001) 624-629
29. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
30. Sharoni E., Song H.K., Peterson R.J., et al. Off pump coronary artery bypass surgery for significant left ventricular dysfunction. safety, feasibility, and trends in methodology over time-an early experience. Heart 92 (2006) 499-502
31. Calafiore A.M., Di Giammarco G., Teodori G., et al. Late results of first myocardial revascularization in multiple vessel disease. single versus bilateral internal mammary artery with or without saphenous vein grafts. Eur J Cardiothorac Surg 26 (2004) 542-548
32. Doenst T., Velazquez E.J., Beyersdorf F., et al. To STICH or not to STICH. we know the answer, but do we understand the question?. J Thorac Cardiovasc Surg 129 (2005) 246-249
33. Joyce D., Loebe M., Noon G.P., et al. Revascularization and ventricular restoration in patients with ischemic heart failure. the STICH trial. Curr Opin Cardiol 18 (2003) 454-457
34. Carabello B.A. Clinical practice. Aortic stenosis. N Engl J Med 346 (2002) 677-682
35. Lindblom D., Lindblom U., Qvist J., and Lundstrom H. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol 15 (1990) 566-573
36. Connolly H.M., Oh J.K., Schaff H.V., et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction. result of aortic valve replacement in 52 patients. Circulation 101 (2000) 1940-1946
37. deFilippi C.R., Willett D.L., Brickner M.E., et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75 (1995) 191-194
38. Vaquette B., Corbineau H., Laurent M., et al. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function. predictors of operative risk, left ventricular function recovery, and long term outcome. Heart 91 (2005) 1324-1329
39. Dujardin K.S., Enriquez-Sarano M., Schaff H.V., et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 99 (1999) 1851-1857
40. Chaliki H.P., Mohty D., Avierinos J.F., et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 106 (2002) 2687-2693
41. Enriquez-Sarano M., and Tajik A.J. Clinical practice. Aortic regurgitation. N Engl J Med 351 (2004) 1539-1546
42. Lancellotti P., Gerard P.L., and Pierard L.A. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 26 (2005) 1528-1532
43. Patel J.B., Borgeson D.D., Barnes M.E., et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail 10 (2004) 285-291
44. Bolling S.F., Pagani F.D., Deeb G.M., and Bach D.S. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115 (1998) 381-386 discussion 387-388
45. Akasaka T., Yoshida K., Hozumi T., et al. Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery. J Am Coll Cardiol 32 (1998) 1923-1930
46. Wu A.H., Aaronson K.D., Bolling S.F., et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45 (2005) 381-387
47. Srichai M.B., Grimm R.A., Stillman A.E., et al. Ischemic mitral regurgitation. impact of the left ventricle and mitral valve in patients with left ventricular systolic dysfunction. Ann Thorac Surg 80 (2005) 170-178
48. McGee E.C., Gillinov A.M., Blackstone E.H., et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128 (2004) 916-924
49. Yun K.L., Sintek C.F., Miller D.C., et al. Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement. effects on left ventricular volume and function. J Thorac Cardiovasc Surg 123 (2002) 707-714
50. Morishita A., Shimakura T., Nonoyama M., and Takasaki T. Mitral valve replacement in ischemic mitral regurgitation. Preservation of both anterior and posterior mitral leaflets. J Cardiovasc Surg (Torino) 43 (2002) 147-152
51. Miller D.C. Ischemic mitral regurgitation redux-to repair or to replace?. J Thorac Cardiovasc Surg 122 (2001) 1059-1062
52. Gillinov A.M., Wierup P.N., Blackstone E.H., et al. Is repair preferable to replacement for ischemic mitral regurgitation?. J Thorac Cardiovasc Surg 122 (2001) 1125-1141
53. Yamaguchi A., Ino T., Adachi H., et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg 65 (1998) 434-438
54. Buckberg G.D. Ventricular restoration-a surgical approach to reverse ventricular remodeling. Heart Fail Rev 9 (2004) 233-239 discussion 347-351
55. Mickleborough L.L., Carson S., and Ivanov J. Repair of dyskinetic or akinetic left ventricular aneurysm. results obtained with a modified linear closure. J Thorac Cardiovasc Surg 121 (2001) 675-682
56. Ott D.A., Parravacini R., Cooley D.A., et al. Improved cardiac function following left ventricular aneurysm resection. pre- and postoperative performance studies in 150 patients. Tex Heart Inst J 9 (1982) 267-273
57. Athanasuleas C.L., Buckberg G.D., Stanley A.W., et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol 44 (2004) 1439-1445
58. Yamaguchi A., Adachi H., Kawahito K., et al. Left ventricular reconstruction benefits patients with dilated ischemic cardiomyopathy. Ann Thorac Surg 79 (2005) 456-461
59. Sabbah H.N., Sharov V.G., Gupta R.C., et al. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. Circ Res 93 (2003) 1095-1101
60. Oz M.C., Konertz W.F., Kleber F.X., et al. Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg 126 (2003) 983-991
61. Blom A.S., Mukherjee R., Pilla J.J., et al. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation 112 (2005) 1274-1283
62. Advisory Panel Does Not Recommend Approval for New Heart Failure Therapy Researchers and Company Representatives Remain Optimistic. Acorn cardiovascular. Available at: http://www.acorncv.com/about_acorn/documents/FINAL-June222005AcornNewsRelease_001.pdf; 2005.
63. Rosanio S., Schwarz E.R., Ahmad M., et al. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. Am J Cardiol 96 (2005) 710-717
64. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
65. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
66. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
67. Bigger Jr. J.T., and Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575
68. Dries D.L., Exner D.V., Gersh B.J., et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32 (1998) 695-703
69. Hsu L.F., Jais P., Sanders P., et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351 (2004) 2373-2383
70. Cox J.L., Schuessler R.B., D'Agostino Jr. H.J., et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 101 (1991) 569-583
71. Schaff H.V., Dearani J.A., Daly R.C., et al. Cox-Maze procedure for atrial fibrillation. Mayo Clinic experience. Semin Thorac Cardiovasc Surg 12 (2000) 30-37
72. Gillinov A.M., Sirak J., Blackstone E.H., et al. The Cox maze procedure in mitral valve disease. predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg 130 (2005) 1653-1660
73. Brizzio M.E., Navia J.L., Atik F.A., et al. Combined minimally invasive pulmonary vein isolation, left atrial appendage excision and cardiac resynchronization therapy for heart failure. case report. Heart Surg Forum 8 (2005) E249-E252
74. DeBakey M.E. Development of mechanical heart devices. Ann Thorac Surg 79 (2005) S2228-S2231
75. Pagani F.D., Lynch W., Swaniker F., et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant. a strategy to optimize survival and resource utilization. Circulation 100 Suppl (1999) II206-II210
76. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
77. Park S.J., Tector A., Piccioni W., et al. Left ventricular assist devices as destination therapy. a new look at survival. J Thorac Cardiovasc Surg 129 (2005) 9-17
78. Gray NA, Selzman CH. Current status of the total artificial heart. Am Heart J. In press.
79. Cooley D.A., Liotta D., Hallman G.L., et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 24 (1969) 723-730
80. Copeland J.G., Smith R.G., Arabia F.A., et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 351 (2004) 859-867
81. Dowling R.D., Gray Jr. L.A., Etoch S.W., et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 127 (2004) 131-141
82. Nagy R.D., Tsai B.M., Wang M., et al. Stem cell transplantation as a therapeutic approach to organ failure. J Surg Res 129 (2005) 152-160
83. Raeburn C.D., Zimmerman M.A., Arya J., et al. Stem cells and myocardial repair. J Am Coll Surg 195 (2002) 686-693
84. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 6829 (2001) 701-705
85. Ziegelhoeffer T., Fernandez B., Kostin S., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94 (2004) 230-238
86. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
87. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
88. Menasché P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
89. Patel A.N., Geffner L., Vina R.F., et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation. a prospective randomized study. J Thorac Cardiovasc Surg 130 (2005) 1631-1638
90. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction. the MAGIC cell randomised clinical trial. Lancet 363 9411 (2004) 751-756
91. Grines C.L., Watkins M.W., Helmer G., et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105 (2002) 1291-1297
92. Trouillet J.L., Scheimberg A., Vuagnat A., et al. Long-term outcome and quality of life of patients requiring multidisciplinary intensive care unit admission after cardiac operations. J Thorac Cardiovasc Surg 112 (1996) 926-934
93. Roche R.J., Farmery A.D., and Garrard C.S. Outcome for cardiothoracic surgical patients requiring multidisciplinary intensive care. Eur J Anaesthesiol 20 (2003) 719-725
94. Badhar V., and Bolling S.F. Cardiac surgery in the adult. In: Cohn L.J., and Edmunds L.H. (Eds). Nontransplant surgical options for heart failure. 2nd ed. (2003), McGraw-Hill, New York 1515-1526